{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:39:49Z","timestamp":1773344389404,"version":"3.50.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229787","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T14:00:18Z","timestamp":1583244018000},"page":"e0229787","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-4906","authenticated-orcid":true,"given":"Justin C.","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Roman-Urrestarazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Brayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"pone.0229787.ref001","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"A Kolodny","year":"2015","journal-title":"Annual review of public health"},{"issue":"9","key":"pone.0229787.ref002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: trends in emergency department visits for suspected opioid overdoses\u2014United States, July 2016\u2013September 2017","volume":"67","author":"AM Vivolo-Kantor","year":"2018","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"pone.0229787.ref003","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"RA Rudd","year":"2016","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"6","key":"pone.0229787.ref004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/pop.2013.0098","article-title":"Prescription opioid abuse: a literature review of the clinical and economic burden in the United States","volume":"17","author":"R Meyer","year":"2014","journal-title":"Popul Health Manag"},{"issue":"6","key":"pone.0229787.ref005","first-page":"506","volume":"31","author":"LJ Paulozzi","year":"2006","journal-title":"Opioid analgesics and rates of fatal drug poisoning in the United States"},{"issue":"10","key":"pone.0229787.ref006","first-page":"662","volume":"6","author":"TJ Cicero","year":"2005","journal-title":"Trends in abuse of OxyContin\u00ae and other opioid analgesics in the United States: 2002\u20132004"},{"issue":"5","key":"pone.0229787.ref007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ADM.0b013e31829b7afe","article-title":"Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression","volume":"7","author":"LY Chen","year":"2013","journal-title":"J Addict Med"},{"key":"pone.0229787.ref008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2014.10.004","article-title":"Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adults","volume":"145","author":"NG Choi","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0229787.ref009","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/j.pain.0000000000000730","article-title":"Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims","volume":"158","author":"PD Quinn","year":"2017","journal-title":"Pain"},{"key":"pone.0229787.ref010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2018.04.003","article-title":"Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States","volume":"89","author":"VL Short","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"pone.0229787.ref011","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment","volume":"105","author":"CM Jones","year":"2015","journal-title":"Am J Public Health"},{"issue":"2","key":"pone.0229787.ref012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence","volume":"65","author":"CP Thomas","year":"2014","journal-title":"Psychiatric Services"},{"issue":"2","key":"pone.0229787.ref013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-Assisted Treatment With Methadone: Assessing the Evidence","volume":"65","author":"CA Fullerton","year":"2014","journal-title":"Psychiatric Services"},{"issue":"5","key":"pone.0229787.ref014","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","volume":"9","author":"K Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"pone.0229787.ref015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drugalcdep.2012.05.025","article-title":"Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine","volume":"126","author":"MR Lofwall","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"pone.0229787.ref016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsat.2017.07.005","article-title":"The response of substance use disorder treatment providers to changes in macroeconomic conditions","volume":"81","author":"J Cantor","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pone.0229787.ref017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update","volume":"173","author":"KT Brady","year":"2016","journal-title":"Am J Psychiatry"},{"key":"pone.0229787.ref018","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2007","author":"United States Department of Health and Human Services","year":"2007"},{"key":"pone.0229787.ref019","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2008","author":"United States Department of Health and Human Services","year":"2008"},{"key":"pone.0229787.ref020","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2009","author":"United States Department of Health and Human Services","year":"2009"},{"key":"pone.0229787.ref021","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2010","author":"United States Department of Health and Human Services","year":"2010"},{"key":"pone.0229787.ref022","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2011","author":"United States Department of Health and Human Services","year":"2011"},{"key":"pone.0229787.ref023","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2012","author":"United States Department of Health and Human Services","year":"2012"},{"key":"pone.0229787.ref024","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2013","author":"United States Department of Health and Human Services","year":"2013"},{"key":"pone.0229787.ref025","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2014","author":"United States Department of Health and Human Services","year":"2014"},{"key":"pone.0229787.ref026","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2015","author":"United States Department of Health and Human Services","year":"2015"},{"key":"pone.0229787.ref027","volume-title":"Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (NSSATS), 2016","author":"United States Department of Health and Human Services","year":"2016"},{"key":"pone.0229787.ref028","unstructured":"U.S. Department of Commerce Economics and Statistics Administration U.S. Census Bureau. Census Regions and Divisions of the United States."},{"issue":"1","key":"pone.0229787.ref029","volume":"2","author":"TF Kresina","year":"2009","journal-title":"United States government oversight and regulation of medication assisted treatment for the treatment of opioid dependence"},{"key":"pone.0229787.ref030","unstructured":"Stata Statistical Software. Release 14 [computer program]. 2013."},{"issue":"4","key":"pone.0229787.ref031","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11916-018-0679-3","article-title":"Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain","volume":"22","author":"N Vadivelu","year":"2018","journal-title":"Current pain and headache reports"},{"key":"pone.0229787.ref032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/JPR.S127602","article-title":"Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone\/naltrexone extended-release product","volume":"11","author":"JV Pergolizzi","year":"2018","journal-title":"J Pain Res"},{"issue":"8","key":"pone.0229787.ref033","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1377\/hlthaff.2010.0532","article-title":"The evidence doesn\u2019t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine","volume":"30","author":"RE Clark","year":"2011","journal-title":"Health Affairs"},{"issue":"12","key":"pone.0229787.ref034","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1080\/10826084.2016.1200097","article-title":"Should the United States Government Repeal Restrictions on Buprenorphine\/Naloxone Treatment?","volume":"51","author":"K Blum","year":"2016","journal-title":"Substance Use & Misuse"},{"issue":"4","key":"pone.0229787.ref035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.15288\/jsad.2015.76.644","article-title":"The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis","volume":"76","author":"HK Knudsen","year":"2015","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"pone.0229787.ref036","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2015.09.032","article-title":"States\u2019 implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence","volume":"157","author":"HK Knudsen","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0229787.ref037","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.drugalcdep.2016.08.642","article-title":"Buprenorphine physician supply: Relationship with state-level prescription opioid mortality","volume":"173","author":"HK Knudsen","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0229787.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren't physicians prescribing more buprenorphine?","volume":"78","author":"AS Huhn","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"pone.0229787.ref039","first-page":"31","article-title":"Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers","volume":"1","author":"LG Duncan","year":"2015","journal-title":"J Addict Med Ther Sci"},{"issue":"4","key":"pone.0229787.ref040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jsat.2011.05.005","article-title":"A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment","volume":"41","author":"TR Rieckmann","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"pone.0229787.ref041","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/appi.ps.201600397","article-title":"National Overview of Medication-Assisted Treatment for American Indians and Alaska Natives With Substance Use Disorders","volume":"68","author":"T Rieckmann","year":"2017","journal-title":"Psychiatric Services"},{"issue":"4","key":"pone.0229787.ref042","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1606\/1044-3894.4242","article-title":"Service Provider Views of Oxycontin Use on an Indian Reservation: Traumatic Effects on the Tribal Community. Families in Society","volume":"93","author":"S Momper","year":"2012","journal-title":"The Journal of Contemporary Social Services"},{"key":"pone.0229787.ref043","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jsat.2016.05.007","article-title":"A National Study of American Indian and Alaska Native Substance Abuse Treatment: Provider and Program Characteristics","volume":"68","author":"T Rieckmann","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"pone.0229787.ref044","first-page":"23","volume":"13","author":"RA Rosenblatt","year":"2015","journal-title":"Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder"},{"issue":"3","key":"pone.0229787.ref045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1468-0009.12137","article-title":"Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties","volume":"93","author":"BD Stein","year":"2015","journal-title":"The Milbank Quarterly"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T14:00:36Z","timestamp":1583244036000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229787"}},"subtitle":[],"editor":[{"given":"Judith I.","family":"Tsui","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229787","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]}}}